Advisor Group Holdings, Inc. Axsome Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,635 shares of AXSM stock, worth $152,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,635

Previous 2,522 35.17%

Holding current value

$152,332

Previous $203,000 28.08%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$78.93 - $95.84 $70,010 - $85,010	-887 Reduced 35.17%	1,635 $146,000
Q2 2024 Aug 13, 2024	SELL	$65.72 - $80.5 $18,664 - $22,862	-284 Reduced 10.12%	2,522 $203,000
Q1 2024 May 10, 2024	SELL	$69.39 - $97.64 $116,783 - $164,328	-1,683 Reduced 37.49%	2,806 $223,000
Q4 2023 Feb 12, 2024	SELL	$57.42 - $83.61 $40,194 - $58,527	-700 Reduced 13.49%	4,489 $357,000
Q3 2023 Nov 13, 2023	SELL	$69.25 - $82.21 $49,375 - $58,615	-713 Reduced 12.08%	5,189 $362,000
Q2 2023 Aug 10, 2023	SELL	$58.41 - $90.35 $58,526 - $90,530	-1,002 Reduced 14.51%	5,902 $424,000
Q1 2023 May 12, 2023	BUY	$58.39 - $75.0 $105,569 - $135,600	1,808 Added 35.48%	6,904 $425,000
Q4 2022 Feb 10, 2023	SELL	$39.94 - $79.72 $40,738 - $81,314	-1,020 Reduced 16.68%	5,096 $393,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $35,879 - $69,500	995 Added 19.43%	6,116 $272,000
Q2 2022 Aug 10, 2022	SELL	$21.74 - $46.75 $7,217 - $15,521	-332 Reduced 6.09%	5,121 $197,000
Q1 2022 May 04, 2022	SELL	$23.7 - $41.39 $10,617 - $18,542	-448 Reduced 7.59%	5,453 $237,000
Q3 2021 Nov 05, 2021	BUY	$19.91 - $68.26 $34,922 - $119,728	1,754 Added 42.3%	5,901 $195,000
Q2 2021 Aug 02, 2021	BUY	$50.63 - $73.5 $41,465 - $60,196	819 Added 24.61%	4,147 $279,000
Q1 2021 May 13, 2021	BUY	$55.91 - $81.44 $88,617 - $129,082	1,585 Added 90.94%	3,328 $189,000
Q4 2020 Feb 10, 2021	SELL	$66.31 - $86.52 $8,355 - $10,901	-126 Reduced 6.74%	1,743 $142,000
Q3 2020 Nov 12, 2020	SELL	$68.34 - $85.84 $54,672 - $68,672	-800 Reduced 29.97%	1,869 $133,000
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $104,228 - $206,262	-2,090 Reduced 43.92%	2,669 $219,000
Q1 2020 May 18, 2020	BUY	$41.2 - $101.31 $196,070 - $482,134	4,759 New	4,759 $280,000

Others Institutions Holding AXSM

# of Institutions

326

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Axsome Therapeutics, Inc. Transaction History